Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women

by W. Snippenburg, van, F.J.B. Nellen, C. Smit, A.M.J. Wensing, M.H. Godfried, T. Mudrikova
Published 2017-01-01

Allogeneic stem cell transplantation in HIV-1 infected individuals

by A.M.J. Wensing, J.L. Diez Martin, G. Hutter, J. Kuball, M. Nijhuis, A. Saez-Cirion, V. Rocha, J. Schulze zur Wiesch, J. Martinez-Picado
Published 2015-12-01

The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial

by J. Symons, S.F.L. van Lelyveld, W. de Spiegelaere, A.M.J. Wensing, J. Drylewicz, A.I.M. Hoepelman, P.U. Cameron, H. Lu, T. Mota, A.I. Dantanarayana, L. Vandekerckhove, S.R. Lewin, K. Tesselaar, M. Nijhuis
Published 2017-12-01

Post-mortem analysis of HIV-1 reservoir after allogeneic transplantation using stem cells

by M. Nijhuis, A. Bruns, M. Salgado, A.J. Stam, P.M. Ellerbroek, K. Tesselaar, P. van Ham, T.C.M. de Jong, G. Hutter, S.S. Zeerleder, J.T. van der Meer, L.L.A. Brosens, J. Martinez-Picado, J. Kuball, A.M.J. Wensing
Published 2015-12-01